340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

PhRMA Pushes to Reopen 340B Statute on Capitol Hill

Hospitals say legislative changes could put program in jeopardy 

The drug industry has announced it wants Congress to reopen the original 340B law to give the Health Resources and Services Administration additional rule- making authority to regulate the program. … [Read more...]

Goodbye, 340B Mega-Reg. Hello, 340B Guidance

Welcome back, proposed rules on manufacturer sanctions and dispute resolution 

November 14, 2014—The Health Resources and Services Administration said for the record this morning that, in 2015, it  "plans to issue a proposed guidance for notice and comment that will address key policy issues raised by various stakeholders committed to the integrity of the 340B program."   … [Read more...]

Congress Asked to Investigate Genentech’s Specialty-Drug Switch

10 major academic medical centers seek expedited review 

November 14, 2014—Ten of the nation's leading academic medical centers have asked Congress to investigate Genentech's decision to move the world’s three top-selling cancer drugs into the more expensive specialty distribution channel. … [Read more...]

HRSA Withdraws 340B Mega-Reg, Will Issue Guidance Instead

Publication expected early next year 

November 13, 2014—The Health Resources and Services Administration is withdrawing its planned comprehensive 340B program regulation tomorrow morning and instead will issue guidance early next year revising policies for key program elements. … [Read more...]

MedPAC Briefed About 340B Paper Requested by Lawmakers

Commission will not vote on findings or make recommendations to Congress 

November 10, 2014—Medicare Payments Advisory Commission staff members briefed the panel last week about a commission paper on the 340B program requested by congressional Medicare oversight committees.   … [Read more...]

In Elections’ Wake, New Senate Leadership and a New GAO Study on 340B

Report is due to be issued in mid-2015 

November 5, 2014—U.S. Senate committees with responsibility for the 340B drug discount program will have new leaders starting early next year following the GOP's strong showing in yesterday's midterm elections.      … [Read more...]

OIG Assessing Risk of Medicaid MCO Rebates on 340B-Purchased Drugs

Also, study about 340B and Medicare Part B is still on track 

November 4, 2014—The Department of Health and Human Services Office of Inspector General is assessing the risk of manufacturer discounts and rebates both being paid on 340B-purchased drugs dispensed to Medicaid managed care beneficiaries, the OIG said in its fiscal year 2015 work plan.   … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health